COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit Post published:September 21, 2022 Post category:Press Release
COMPASS Pathways to participate in three upcoming investor events Post published:September 1, 2022 Post category:Press Release
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights Post published:August 4, 2022 Post category:Press Release
COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord Annual Growth Conference Post published:August 2, 2022 Post category:Press Release
COMPASS Pathways launches phase II clinical trial of psilocybin therapy in anorexia nervosa Post published:July 29, 2022 Post category:Press Release
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022 Post published:July 26, 2022 Post category:Press Release
COMPASS Pathways appoints Kabir Nath as Chief Executive Officer Post published:July 20, 2022 Post category:Press Release
COMPASS Pathways presents largest ever study of psilocybin therapy, at American Psychiatric Association annual meeting Post published:May 22, 2022 Post category:Press Release
COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers Post published:April 20, 2022 Post category:Press Release
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK Post published:March 24, 2022 Post category:Press Release